Market News - Page 578

Harworth Group plc (“Harworth” or “the Group”), a leading regenerator of land and property for development and investment, today provides a trading update for the financial year ended 31 December 2019….

Camellia Plc announces the following trading update for the year ended 31 December 2019….

BHP Group issue operation review for the half-year ended 31 December 2019…

Further to recent press speculation, intu properties plc (“intu” or the “Company”) continues to make progress in its strategy to fix the balance sheet….

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US for patients with metastatic castration-resistant prostate cancer (mCRPC) and deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene mutations, who have progressed following prior treatment with a new hormonal agent….

AstraZeneca's Imfinzi (durvalumab) and tremelimumab, an anti-CTLA4 antibody and potential new medicine, have both been granted Orphan Drug Designation (ODD) in the US for the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

…

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces its trading update for the year ended 31st December 2019, ahead of reporting its Preliminary Results on 24th March 2020….

Further to Accrol's announcements dated 21 January 2019 (RNS number 6698N) and 27 March 2019 (RNS number 1694U) notifying the market of an FCA investigation into the Company, Accrol is pleased to announce that the FCA has notified it that the FCA has closed its investigation and will not be taking any action…